AngioDynamics to Hold Fiscal 2006 Second Quarter Financial Results Conference Call on Monday, December 19, 2005 QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 13, 2005--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release fiscal 2006 second quarter results after the market

AngioDynamics to Present at the First Albany Capital Annual Growth Conference on December 7th QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 2, 2005--AngioDynamics, Inc., (Nasdaq:ANGO) today announced that its president and chief executive officer, Eamonn P.

Radiofrequency Ablation Treatment Shown to Improve Survival Rates and Patient Outcomes Across Multiple Organs

FREMONT, Calif.--(BUSINESS WIRE)--Nov. 22, 2005-- Medicare Increases Hospital Outpatient Payment for Liver Cancer Radiofrequency Ablation

RITA Medical Resumes Volume Shipments of HABIB(TM)4X Resection Device FREMONT, Calif., Nov. 15 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it resumed volume shipments of the

AngioDynamics Launches Sotradecol at American College of Phlebology Meeting AngioDynamics Launches Sotradecol at American College of Phlebology Meeting QUEENSBURY, N.Y., Nov 07, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc., (Nasdaq:ANGO) today announced it will launch Sotradecol ™ at the 19th

RITA Medical Systems Reports Third Quarter Results RITA Medical Systems Reports Third Quarter Results FREMONT, Calif., Nov. 1 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today reported financial

AngioDynamics to Present at Rodman & Renshaw TechVest Seventh Annual Healthcare Conference AngioDynamics to Present at Rodman & Renshaw TechVest Seventh Annual Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 31, 2005--AngioDynamics, Inc., (Nasdaq: ANGO) today announced that its

RITA Medical Systems Announces Third Quarter 2005 Earnings Release Date and Conference Call FREMONT, Calif., Oct 24, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it will release financial results for the third quarter ended

Clinical Trial at Arkansas Cancer Research Center Demonstrates Breast Cancer Treatment Using RITA Medical Systems Radiofrequency Ablation Products Reduces Re-Excision Rates by 86% FREMONT, Calif. & LITTLE ROCK, Ark.--(BUSINESS WIRE)--Oct. 19, 2005-- Presentation Made October 18th at the 2005

RITA Medical to Present at the C. E. Unterberg, Towbin Emerging Growth Life Sciences Conference FREMONT, Calif., Oct. 19 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been

RITA Medical Appoints Michael Angel as Chief Financial Officer Mr. Angel Brings More Than 27 Years of Financial Management and Corporate Development Expertise to RITA FREMONT, Calif., Oct. 18 /PRNewswire-FirstCall/ -- RITA Medical Systems (Nasdaq: RITA), today announced the appointment of Michael

AngioDynamics Signs Exclusive Agreement with Bioniche Pharma Group Limited for Distribution of Sotradecol(TM); Revises Guidance Upwards AngioDynamics Signs Exclusive Agreement with Bioniche Pharma Group Limited for Distribution of Sotradecol(TM); Revises Guidance Upwards QUEENSBURY, N.Y.--(BUSINESS

Company Expects to Generate Revenue of $11.1 to $11.3 Million

Net Loss Per Share Expected to Be Reduced to Between $0.00 and $0.02

AngioDynamics Comments on Patent Infringement Lawsuit Related to VenaCure Laser Products QUEENSBURY, N.Y.--(BUSINESS WIRE)--Oct. 7, 2005--AngioDynamics, Inc. (Nasdaq: ANGO) today announced the Company has become aware that it has been added to a patent infringement suit originally filed by VNUS

Retired Medtronic Executive Brings 26 Years of Medical Device Experience to the Board

RITA Medical Systems Delays Shipment of Habib(TM) 4X FREMONT, Calif., Sept. 27 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) a medical device company focused solely on cancer therapies, today announced that domestic shipments of the recently launched Habib 4X resection device

AngioDynamics Reports Net Income Up 70% On 25% Revenue Gain; Conference Call to Begin Today At 4:30 pm ET QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 27, 2005--AngioDynamics, Inc. (NASDAQ:ANGO) today announced financial results for the 13 weeks ended August 27, 2005.

RITA Medical to Present at the UBS Global Life Sciences Conference FREMONT, Calif., Sept. 20 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced that it has been invited to present at the

AngioDynamics to Hold Fiscal 2006 First Quarter Financial Results Conference Call on Tuesday, September 27, 2005 QUEENSBURY, N.Y., Sep 20, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (Nasdaq NM:ANGO) today announced that the company will release fiscal 2006 first quarter results after the market